Cargando…

KLF6-SV1 is a new prognostic biomarker in postoperative patients with non-small cell lung cancer

OBJECTIVES: Non-small cell lung cancer (NSCLC) is aggressive and associated with a poor prognosis. Recent studies have revealed that several genes are involved in the origin and progression of NSCLC. Kruppel-like factor 6 (KLF6) inactivation has been shown in some malignant tumors. KLF6-SV1, as one...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Nan, Li, Zhe, Xiao, Wei, Yang, Fei, Gao, Wei, Sun, Zhi-Gang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6165774/ https://www.ncbi.nlm.nih.gov/pubmed/30310314 http://dx.doi.org/10.2147/CMAR.S171805

Ejemplares similares

The KLF6 splice variant KLF6-SV1 promotes proliferation and invasion of non-small cell lung cancer by up-regultating PI3K-AKT signaling pathway
por: Zhang, Nan, et al.
Publicado: (2019)

Expression of KLF6-SV2 in colorectal cancer and its impact on proliferation and apoptosis
por: Zhang, Biao, et al.
Publicado: (2018)

KLF6SV1 siRNA inhibits proliferation of human lens epithelial cells
por: Su, Ying, et al.
Publicado: (2012)

Overexpression of the Oncogenic Variant (KLF6-SV1) in Young NPC Patients and Correlation with Lack of E-Cadherin
por: Debouki-Joudi, Saoussen, et al.
Publicado: (2018)

Autologous T cells expressing the oncogenic transcription factor KLF6-SV1 prevent apoptosis of chronic lymphocytic leukemia cells
por: Kokhaei, Parviz, et al.
Publicado: (2018)

SV-VATS exhibits dual intraoperative and postoperative advantages
por: Xu, Jia-Yang, et al.
Publicado: (2021)

Prognostic biomarkers correlated with immune infiltration in non‐small cell lung cancer
por: Xu, Fei, et al.
Publicado: (2022)

Knockdown of KLF5 promotes cisplatin‐induced cell apoptosis via regulating DNA damage checkpoint proteins in non‐small cell lung cancer
por: Zhang, Hao, et al.
Publicado: (2019)

miR-185 Inhibits the Proliferation and Invasion of Non-Small Cell Lung Cancer by Targeting KLF7
por: Zhao, Lili, et al.
Publicado: (2019)

A Population-Based Study on the Prognostic factors and Efficacy of Adjuvant Chemotherapy in the Postoperative Stage for Patients with Stage IIA Non-Small Cell Lung Cancer
por: Wang, Wei, et al.
Publicado: (2022)

Prognostic significance of thymidylate synthase in postoperative non-small cell lung cancer patients
por: Zhao, Hong-Yun, et al.
Publicado: (2014)

miR-486 as an unfavorable prognostic biomarker for patients with non-small cell lung cancer
por: Gao, Zhao-Jia, et al.
Publicado: (2020)

Clinical and prognostic significance of signal transducer and activator of transcription 3 and mucin 1 in patients with non-small cell lung cancer following surgery
por: Sun, Zhi-Gang, et al.
Publicado: (2018)

Combination of CALR and PDIA3 is a potential prognostic biomarker for non-small cell lung cancer
por: Wang, Ke, et al.
Publicado: (2017)

Clinical Features and Prognostic Factor of Thoracic Postoperative Oligo-Recurrence of Non-Small-Cell Lung Cancer
por: Yuan, Qi, et al.
Publicado: (2020)

KLF2 is a clinical diagnostic and treatment biomarker of breast cancer
por: Li, Ya-Zhao, et al.
Publicado: (2023)

Molecular profiling and prognostic biomarkers in chinese non-small cell lung cancer cohort
por: Shen, Fangfang, et al.
Publicado: (2023)

Prognostic Implications of Postoperative Infectious Complications in Non-Small Cell Lung Cancer
por: Jang, Hyo-Jun, et al.
Publicado: (2018)

KLF16 promotes pancreatic adenocarcinoma cell proliferation and migration by positively regulating SMAD6
por: Mi, Wei, et al.
Publicado: (2022)

Epithelial-mesenchymal reprogramming by KLF4-regulated Rictor expression contributes to metastasis of non-small cell lung cancer cells
por: Zhou, Huiling, et al.
Publicado: (2022)

Platelet releasates promote the proliferation of hepatocellular carcinoma cells by suppressing the expression of KLF6
por: He, Ao-Di, et al.
Publicado: (2017)

SIRT6 drives epithelial-to-mesenchymal transition and metastasis in non-small cell lung cancer via snail-dependent transrepression of KLF4
por: Li, Ziming, et al.
Publicado: (2018)

Clinicopathologic features and prognostic implications of NOK/STYK1 protein expression in non-small cell lung cancer
por: Chen, Peng, et al.
Publicado: (2014)

SP1-induced long non-coding RNA SNHG6 facilitates the carcinogenesis of chondrosarcoma through inhibiting KLF6 by recruiting EZH2
por: Pu, Fei-Fei, et al.
Publicado: (2021)

SPARC expression and prognostic value in non-small cell lung cancer
por: Huang, Yan, et al.
Publicado: (2012)

Role of prognostic nutritional index in postoperative radiotherapy for non‐small cell lung cancer
por: Ryu, Hyejo, et al.
Publicado: (2023)

Exosomal miR-141 promotes tumor angiogenesis via KLF12 in small cell lung cancer
por: Mao, Shuangshuang, et al.
Publicado: (2020)

KLF15 promotes the proliferation and metastasis of lung adenocarcinoma cells and has potential as a cancer prognostic marker
por: Gao, Lihua, et al.
Publicado: (2017)

Evaluation of Postoperative Radiotherapy Effect on Survival of Resected Stage III-N2 Non-small Cell Lung Cancer Patients
por: Gao, Fei, et al.
Publicado: (2020)

KLF 6: a mitochondrial regulator in the kidney
por: Mallipattu, Sandeep K., et al.
Publicado: (2015)

WDR5 is a prognostic biomarker of brain metastasis from non-small cell lung cancer
por: Li, Zheng, et al.
Publicado: (2022)

Osteopontin is a prognostic biomarker in non-small cell lung cancer
por: Rud, Ane Kongsgaard, et al.
Publicado: (2013)

Exosomal proteins as prognostic biomarkers in non‐small cell lung cancer
por: Sandfeld-Paulsen, B., et al.
Publicado: (2016)

Apremilast ameliorates ox-LDL-induced endothelial dysfunction mediated by KLF6
por: Wang, Hao, et al.
Publicado: (2020)

Serum miR-185 Is a Diagnostic and Prognostic Biomarker for Non-Small Cell Lung Cancer
por: Liu, Jinghao, et al.
Publicado: (2020)

MicroRNA-103 modulates tumor progression by targeting KLF7 in non-small cell lung cancer
por: Li, Ke, et al.
Publicado: (2020)

The deubiquitinase OTUD1 inhibits non‐small cell lung cancer progression by deubiquitinating and stabilizing KLF4
por: Ma, Xiaoyan, et al.
Publicado: (2022)

SV40 and human mesothelioma
por: Carbone, Michele, et al.
Publicado: (2020)

Prognostic Impact of Postoperative Complications in High-Risk Operable Non-small Cell Lung Cancer
por: Lee, Seungwook, et al.
Publicado: (2022)

Comprehensive analysis of KLF2 as a prognostic biomarker associated with fibrosis and immune infiltration in advanced hepatocellular carcinoma
por: Chen, Xue-Qin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jh893g8hmp2t39vng4eshnccsg